Imigran Radis (Sumatriptan)

Sumatriptan works by selectively stimulating serotonin 5‑HT1B and 5‑HT1D receptors. This causes constriction of dilated cranial blood vessels and blocks the release of pain‑triggering neuropeptides, thereby reducing migraine pain and associated symptoms.

The appropriate dose of Imigran Radis is determined by a qualified prescriber based on individual patient factors. Patients should follow the dosing instructions provided by their healthcare professional and not self‑adjust the dose.

Safety of sumatriptan during pregnancy or lactation has not been definitively established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their physician before using Imigran Radis.

To place an order, submit an enquiry on the Imigran Radis product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Imigran Radis (sumatriptan) belongs to the triptan class, which is generally more effective for moderate to severe migraine attacks than simple analgesics. Compared with newer CGRP antagonists, triptans act via serotonin receptors and have a well‑established efficacy profile, though they carry specific vascular contraindications.

Imigran Radis should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain its stability and potency.

Imigran Radis is taken orally, usually as a tablet. The tablet should be swallowed whole with water, preferably at the first sign of a migraine. Patients should not crush, chew, or dissolve the tablet unless specifically instructed by a healthcare professional.

Serious risks include coronary vasospasm, severe hypertension, and serotonin syndrome, especially when combined with other serotonergic drugs. Patients should seek immediate medical attention if they experience chest pain, a sudden rise in blood pressure, or symptoms such as agitation, fever, or muscle rigidity.

Imigran Radis is contraindicated in individuals with a history of ischemic heart disease, uncontrolled hypertension, cerebrovascular disorders, hemiplegic or basilar migraine, and those taking MAO inhibitors within the past two weeks. It should also be avoided in patients with known hypersensitivity to sumatriptan.